Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer

More effective therapy is needed to improve the survival of patients with advanced and recurrent ovarian cancer. Preclinical and early clinical studies with single molecular targeted agents have shown limited antitumor activity in ovarian cancer, likely due to compensation by alternative growth/surv...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Wen, Ernest S. Han, Thanh H. Dellinger, Leander X. Lu, Jun Wu, Richard Jove, John H. Yim
Format: Artigo
Language:Inglês
Published: MDPI AG 2020-09-01
Series:Cancers
Subjects:
sunitinib
dasatinib
everolimus
targeted therapy
combination
ovarian cancer
Online Access:https://www.mdpi.com/2072-6694/12/9/2586
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items